Rhythm Pharmaceuticals buy Bank of America Co.
Start price
17.03.26
/
50%
€77.50
Target price
17.03.27
€120.90
Performance (%)
-1.29%
Price
17.03.26
€75.00
Summary
This prediction is currently active. With a performance of -1.29%, the BUY prediction for Rhythm Pharmaceuticals by Bank_of_America_Co_ is down slightly. This prediction currently runs until 17.03.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | -1.29% |
| iShares Core DAX® | -0,68 % |
| iShares Nasdaq 100 | -0,03 % |
| iShares Nikkei 225® | -0,54 % |
| iShares S&P 500 | -0,21 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Bank of America Corporation from $145.00 to $139.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€76.50
10.07.25
10.07.25
€80.90
10.07.26
10.07.26
0.00%
17.03.26
17.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€50.50
07.04.25
07.04.25
€57.38
07.04.26
07.04.26
51.49%
17.03.26
17.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€20.80
01.08.23
01.08.23
-
01.08.24
01.08.24
97.12%
02.08.24
02.08.24